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Abstract: Objective: To quantitate the omega-3 status in a cohort of Australian adolescents. 
Design, Setting and Participants: A cross-sectional descriptive study of 251 apparently healthy adolescents (192 female, 
59 male) aged 15-17 years, in year 11, from 10 schools within the Northern Sydney and Central Coast areas of New 
South Wales. Participants provided a morning non-fasting blood sample via finger-prick and written answers to specific 
demographic and lifestyle questions. Omega-3 index was calculated by adding %EPA and %DHA values in the whole 
blood. Equivalent erythrocyte omega-3 index values were obtained by using conversion factors (1.33 for EPA and 2.22 
for DHA) from published erythrocyte/whole blood values. 
Main Outcome Measures: Quantitation of the individual, and estimation of the group average, blood omega-3 Index.  
Results: The blood omega-3 Index for this adolescent cohort ranged from 2.1-22.3 with a mean of 8.3±3.2, and median 
of 7.8. On average males had a higher omega-3 Index compared to females (10.5±3.7 vs 7.7±2.6, p<0.001). Fifty three 
percent of adolescents tested had an omega-3 Index below the optimum of >8. Three percent had an Index of <4, 
placing them in the high risk category for disease.  
On average, adolescents from low or medium socioeconomic communities had a significantly lower omega-3 Index 
compared to those from higher socioeconomic neighbourhoods (mean difference=1.4, p=0.018). Overall 20% of boys 
and 17% of girls reported regularly taking omega-3 supplements. Regular use of omega-3 supplements was associated 
with a higher average omega-3 Index (9.8±3.7, n=44 compared to 8.0±3.0, n=203, p=0.001 in those not taking 
supplements).  
Conclusion: This study indicates that Australian adolescents, even when from advantaged homes, have a high 
probability of below optimum omega-3 levels. As reduced omega-3 levels are linked to conditions of public health 
concern such as diabetes, asthma and depression, targeted strategies to improve the omega-3 status in the childhood 
population may be warranted. 
Keywords: Polyunsaturated fatty acids, child, health, brain, depression. 
INTRODUCTION 
The importance of the essential, dietary derived, 
polyunsaturated fatty acids (PUFAs) omega-6 and 
omega-3 to human health were first reported by Burr 
and Burr in two landmark publications almost 90 years 
ago [1,2]. Though some decades elapsed before 
PUFAs commanded a reasonable priority in medical 
research an escalating body of evidence now indicates 
that adequate levels of both omega-6 and omega-3 
PUFAs are required to maintain optimum health 
throughout life [3].
 
A western diet typically supplies substantial 
amounts of omega-6 through ingestion of  
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manufactured foods containing oils such as corn, 
safflower, grape-seed, sunflower, peanut and soybean. 
However this same diet has limited capacity to provide 
omega-3 [4], suggesting that ingestion of omega-3 
PUFAs may not be optimal in either adult or adolescent 
populations. 
This is of concern as research now indicates that 
sufficient intakes of omega-3 PUFAs is helpful in the 
reduction of a wide range of chronic medical conditions 
including cardiovascular disease, depression, anxiety, 
diabetes, asthma, and rheumatoid arthritis [5-9]. 
The multiple beneficial effects attributed to omega-
3s are due to the involvement of this family of PUFAs, 
including alpha linolenic acid (ALA), ecosopentanoic 
acid (EPA) and docosohexanoic acid (DHA) and their 
derivatives (eicosanoids, resolvins and protectins), in a 
diverse range of biochemical pathways and cellular 
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functions including metabolism, cell membrane fluidity, 
intracellular signaling and gene expression [10]. 
Through these pathways omega-3s influence cell 
growth and tissue repair and help modulate aspects of 
inflammation and immunity [11]; functions that are 
important both to the developing adolescent and 
mature adult. 
While a considerable body of data is available on 
the omega-3 status of adults, relatively few studies 
have measured PUFA levels in the child/adolescent; a 
time of considerable physiological development both 
systemically and in the central nervous system.  
The omega-3 PUFA DHA is the most abundant fatty 
acid in the human brain. During adolescence the brain 
goes through a critical stage of neural development 
[12], where selective synaptic elimination and neural 
network remodelling may be influenced by 
environmental factors. DHA has been shown to 
progressively increase in concentration in the brain 
from childhood through adolescence, peaking at 
around 18 years to adult levels before declining in older 
age [13].  
While the functional importance of this is still being 
elucidated, dietary DHA intake has been associated 
with alterations in activity in cortical attention networks 
during sustained attention in healthy boys [14]. In 
addition, fish consumption (a good source of the 
omega-3s DHA and EPA) at age 15 has been 
positively correlated with intelligence at 18 [15]. In fact 
two separate studies have observed that higher fish 
intake is associated with more advanced vocabulary 
and higher grades among adolescents [16,17].  
Possibly stemming from its relationship to neural 
function, omega-3 intake has long been associated 
with improvements in mood disorders in adults [18]. 
While limited data is available for adolescents a recent 
study reported that higher intakes of fish, EPA, and 
DHA were independently associated with a lower 
prevalence of depressive symptoms in male 
adolescents [19,20].
 
Omega-3 intake is also linked mechanistically with 
vascular health and therefore risk of both cardio and 
cerebro-vascular disease [21]. As omega-3 metabolites 
affect inflammatory activity they are thought to reduce 
development of pro-atherosclerotic processes. A recent 
study by O’Sullivan et al. observed that in boys, higher 
omega-3 levels were independently associated with 
key cardiovascular risk factors such as total cholesterol 
and diastolic blood pressure suggesting that omega-3 
levels may influence cardiovascular health even in the 
young [22]. 
Given the relationship between essential PUFA 
levels and multiple health conditions, assessment of an 
individual’s omega-3 status seems prudent. Block et al. 
showed a significant association between acute 
coronary syndrome (ACS) case status and blood cell 
EPA + DHA levels, expressed as a percentage of total 
membrane fatty acids [23]. This is known as the 
omega-3 Index. On the basis of these observations the 
cut points for cardiovascular risk were determined to be 
<4 = high risk, 4-8 = intermediate risk, >8 = low risk 
[23]. Harris, has since argued convincingly for the 
omega-3 Index as both a risk marker and risk factor for 
cardiovascular disease [24]. More recently work by 
Baghi et al. supports an association between low 
omega-3 Index (<4) and risk for both cardiovascular 
and major depressive disorder (MDD) in adults [25].
 
While a foundation for disease risk based on 
omega-3 status in adults has been developed, a 
comparable body of knowledge in relation to omega-3 
status and the child/adolescent population is presently 
absent.  
Two fundamental questions need to be answered:  
1) What is the current status of omega-3 levels in 
children/adolescents in various locations around 
the world?  
2) Do adult cut-points represent relevant ranges for 
the assessment of disease risk in children/ 
adolescents? 
While answers to the second question await further 
research, initial characterisation of omega-3 levels in 
the younger age groups has begun. A recent study by 
O’Sullivan et al. in Western Australia reported a mean 
omega-3 Index for 13 to 15 year old children as 
4.90±1.04 (range 1.41-8.42), where 15.6% of 
adolescents had an Index of <4 putting them in the 
high risk category [22]. Complementing the work done 
by O’Sullivan et al. the current study reports the 
measured omega-3 status from 251, 15 to 17 year old, 
adolescents from the east Australian state of New 
South Wales.  
METHODS 
A cross-sectional survey of 251 participants (192 
female, 59 male) aged 15 to 17 years was carried out.  
Suboptimal Omega-3 Levels in Australian Adolescents International Journal of Child Health and Nutrition, 2013 Vol. 2, No. 4      311 
Morphometric Analysis 
The height and weight of each participant was 
measured using a standard Wedderburn height stick 
(mm) and Wedderburn body composition analyser BC-
420MA. BMI was calculated appropriate to age using 
the CDC growth charts developed by the National 
Center for Health Statistics in collaboration with the 
National Center for Chronic Disease Prevention and 
Health Promotion (2000). 
Survey Information  
Participants provided written responses to questions 
detailing their personal demographics and use of 
omega-3 supplements. Socioeconomic status (SES) 
was determined according to the Socio-Economic 
Indexes for Areas (SEIFA) published by the Australian 
Bureau of Statistics according to each participant’s 
resident postcode [26].  
Recruitment and Exclusion Criterion 
Participants were recruited from students in year 11 
from 10 schools within the Northern Sydney and 
Central Coast metropolitan areas as part of a larger 
health study. No apparently healthy student was actively 
prevented from participating. All participants provided 
written informed consent signed by both themselves 
and their legal guardian. 
Blood Sample Collection 
A whole blood sample (~200 μL) was collected from 
each participant between 0830 and 1000 hours via 
finger-prick in two heparin anticoagulated capillary 
tubes and stored at 4-8
o
C for <4 hours before 
processing. 
Omega-3 Analysis 
A comprehensive range of fatty acids were 
analyzed by gas chromatography (GC) based on the 
methods of Lepage and Roy [27]. Methanol/toluene 
(4:1, by volume) of 2 mL was mixed with C19:0 (0.2 
mg/mL) and BHT (0.12 g/L), added to the erythrocyte 
pellet and vortexed. On vortexing the sample, 200 μL 
acetyl chloride was added drop-wise to methylate the 
fatty acids, followed by heating to 100 
o
C for 1 hour. 
Samples were allowed to cool, and the reaction was 
stopped by the addition of 5 μL of 6% K2CO3 and 
vortexed. The samples were centrifuged at 3000xg at 4 
o
C for 10 min to separate the layers. The upper layer 
containing toluene and fatty acid methyl esters was 
transferred to a 2 mL glass vial, crimp sealed with a 
teflon-lined cap ready for GC analysis. GC analysis 
was performed with a 30mx0.25mm (DB-225) fused 
carbon-silica column coated with cyanopropylphenyl (J 
& W Scientific, Folsom, CA, USA). The injector and 
dejector ports were set at 250 
o
C and the oven 
temperature at 170 
o
C for 2 minute, increased by 10 
o
C/minute to 190 
o
C, held for 1 minute then increased 
by 3 
o
C/min up to 220 
o
C, which was maintained and 
run for 30 minutes. The injection volume used was 3 μ 
and a split ratio of 10:1. A Hewlett Packard 6890 Series 
Gas Chromatograph with Chemstations version 
A.04.02 was used in the analysis. The GC was outfitted 
with a flame (Palo Alto, CA, USA) ionization detector, 
auto-sampler and auto-detector. The fatty acid methyl 
ester peaks in the samples were identified by 
comparing their retention times with those of a 
standard mixture of fatty acid methyl esters. The 
coefficient of variation for whole blood fatty acid 
analysis is <6%. 
Omega-3 Status and Omega-3 Index Comparison 
For the purpose of this study the whole blood 
omega-3 status is defined as the percentage of the 
long chain polyunsaturated fatty acids, ecosopentanoic 
acid (EPA) + docosohexanoic acid (DHA) relative to 
total fatty acid content in the whole blood. 
To facilitate comparison with published data on the 
red cell omega-3 Index, the whole blood omega-3 
status as determined in this study was converted to the 
equivalent omega-3 Index using an average of the 
conversion factors published by Bell et al. for EPA 
(average of 1.3582 and 1.3186) = 1.3384 and DHA 
(2.2121 and 2.2202) = 2.2242 [28].  
Statistical Analysis 
All statistical analyses were performed using SPSS 
for windows version 19.0. The means and standard 
deviations of the Omega-3 Index values represent the 
estimated values. Levene’s test for equality of 
variances showed that the equality of the variances 
assumption cannot be rejected for all separate groups 
(i.e. gender) comparisons. Two sample t-test is used 
for comparing group means and chi square statistics 
for comparing categorical variables (i.e. gender versus 
disease cut points). Statistical significance is reported 
at 0.05, 0.01 and 0.001 levels. 
Ethical Approval 
This study was conducted in accordance with the 
Helsinki declaration. Approval was obtained from the 
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Human research Ethics Committee (HREC) of the 
Sydney Adventist Hospital (HREC# 06/08). 
RESULTS 
Two hundred and fifty one adolescents from 10 
different Sydney upper north shore (90.4%) and 
Central Coast (9.6%) high schools participated in this 
cross sectional study. The cohort consisted of 24% 
males and 76% females aged 15 to 17 years with a 
group mean BMI of 22.1 (sd=3.7). For boys the BMI 
ranged from 16.8 to 30.5, mean of 22.2 (sd=3.3) and 
for girls, 13.1 to 35.6 with a mean of 22.0 (sd=3.8). The 
omega-3 Index for the group ranged from 2.1 to 22.3 
(Figure 1) with a mean of 8.3±3.2 (Table 1).  
 
Figure 1: Distribution of whole blood omega-3 levels, 
expressed as the omega-3 Index, in a cohort of Australian 
adolescents aged15-17 years, (Reference line on the X axis 
shows the median = 7.83). 
No significant correlations were observed between 
BMI and Omega 3 Index for either the group as a 
whole or male and female subsets.  
As shown in Table 1, on average males had a 
significant 27% higher omega-3 Index compared to 
females (p<0.001). Adolescents from low or medium 
socioeconomic communities had a significant 16% 
lower average omega-3 level compared to those from 
higher socioeconomic neighbourhoods. Adolescents 
from homes where English was not the first language 
showed an 11% greater omega-3 membrane content. 
Although this was statistically significant, the average 
difference between the omega-3 indices for the two 
groups was only 0.9 (Table 1). 
As no data is currently available specifying omega-3 
levels and risk of pathology in children, the established 
cut points for risk of disease in adults is used [23]. 
Table 2 shows that as a group, 53% of adolescents 
in this cohort have below optimum (i.e. <8) omega-3 
levels, with 3% represented in the high risk (i.e. <4) 
category. Females had on average lower omega-3 
levels than males (Table 1) with 62% showing 
concentrations below the optimum (i.e. <8) and 4% in 
the high risk (<4) category. In comparison only 24% of 
male adolescents tested were below the optimum (i.e. 
<8) and none were in the high risk (i.e. <4) category. 
The association between the gender and Omega 3 
Index disease categories was statistically significant 
(2=26.9, df=2, p<0.001). 
A record of self-reported supplement intake was 
also obtained for each participant. Overall 20% of boys 
and 17% of girls reported regularly taking omega-3 
supplements. Supplement intake was not statistically 
biased toward either gender. Adolescents reporting 
regular use of omega-3 supplements had a statistically 
Table 1:  
Demographic 
Omega-3 Index 
Mean(sd) 
Omega-3 Index 
Median 
n p value 
All Adolescents (15-17yrs) 8.3(3.2) 7.8 251 -- 
Male 10.5(3.7) 10.1 59 
Gender *** 
Female 7.7(2.6) 7.3 192 
<0.001 
English 8.1(3.0) 7.7 177 
1
st
 Language* 
other 9.0(3.4) 8.2 74 
0.044 
High 8.5(3.0) 8.1 219 
SES* 
Low/medium 7.1(3.9) 6.7 32 
0.018 
Statistical significance levels *p<0.05, **p<0.01, ***p<0.001. 
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significant higher whole blood omega-3 status 
(9.8±3.7, n=44) compared to adolescents not taking 
supplements (8.0±3.0, n=203) (p=0.001). The higher 
the omega-3 Index the more likely the adolescent was 
to be taking a regular omega-3 supplement (Table 3), 
although the association between taking supplement 
and risk categories was not significant (p=0.074). 
Table 3:  
Omega-3 Index 
Disease cut-points 
% of adolescents in each 
category taking omega-3 
supplements 
<4 (high risk) 0 
4-8 (moderate risk) 12 
>8 (low risk) 25 
 
DISCUSSION 
Omega-(n)-3 polyunsaturated fatty acids include the 
shorter chain precursor alpha-linolenic acid (ALA) and 
the major cell membrane components 
eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA), which are particularly rich in neuronal 
membranes. These have a wide range of effects, from 
immune-modulation and improved vascular function to 
synaptic plasticity.  
A large body of data from studies in adult 
populations provides general endorsement of the 
biological benefits of omega-3. However relatively few 
studies have quantitatively measured omega-3 
incorporation in adolescents.  
While dietary estimates have been reported in 
children [29], the present investigation is one of only 
two studies world-wide that have reported quantitatively 
measured omega-3 levels in an adolescent population.  
The average omega-3 Index reported for the cohort 
of 15 to 17 year old adolescents in the present study 
was higher than that recently reported for a population 
of West Australian 13 to 15 year olds; 8.3±3.2 vs 
4.9±1.0 [22]. While a very significant 53% of 
adolescents in the present study were still below the 
optimum omega-3 Index of >8, only 3% of this cohort 
had an omega-3 Index of <4 placing them in the high 
risk category for degenerative disease (Table 2). This 
was considerably less than the 15.5% reported for the 
West Australian cohort [22]. This discrepancy was 
unexpected though likely reflects key differences 
between the two groups. Both adolescent groups 
represent populations living close to large coastal 
Australian cities. However the significant geographical 
separation of the two populations, one on the east and 
the other the west coast of the continent may be a 
factor. In addition the majority (87%) of adolescents in 
the current study were from homes categorised as 
having high SES while the West Australian cohort were 
derived from suburbs categorised as medium SES (i.e. 
Subiaco, WA). Our data indicates that children from 
higher SES homes have a higher average omega-3 
Index (Table 1). This observation is consistent with that 
reported by O’Sullivan et al. who observed a correlation 
between maternal education, which is linked to SES, 
and omega-3 Index [22]. A high proportion (i.e. 29%) of 
adolescents within our east coast cohort were also 
from migrant families, a demographic that also reported 
higher average omega-3 levels (Table 1). Finally the 
mean omega-3 Index recorded in our east Australian 
cohort is closer to that recently reported for adult 
populations 7.0±1.9% [30], 6.1±1.5% [31]. In addition to 
the points already mentioned it is possible that the 
higher proportion of older students in our cohort, 
reflecting a more developed physiology, may also have 
contributed to a higher average omega-3 Index. 
Unfortunately no data is currently available for 
comparison with an international cohort. 
Irrespective of the relative difference between the 
present adolescent cohort and the previous study, the 
high percentage of adolescents presenting with less 
than optimal omega-3 Index values may be of some 
concern. Adolescence is a time of considerable growth 
and organ development both systemically and within 
the central nervous system. Omega-3 PUFAs influence 
a variety of cell/physiological activities including; 
Table 2:  
% of each gender represented in each category Omega-3 Index 
Disease cut-points 
% of adolescents represented 
in each category 
Male (n=59) Female (n=192) 
<4 (high risk) 3 0 4 
4-8 (moderate risk) 50 24 58 
>8 (low risk) 47 76 38 
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membrane fluidity, neural plasticity, vascular function 
and anti-inflammatory immune signalling. Reduced 
omega-3 levels are therefore associated with the 
pathophysiology of disorders such as cardiovascular 
disease, depression, anxiety, diabetes and asthma [5-
9].
 
While effects on vascular pathology may not be 
clinically obvious in the adolescent, O’Sullivan et al. did 
report a reduction in cardiovascular risk factors in 
adolescent boys with increasing omega-3 levels [22]. 
Consistent with a greater prevalence in females, 
reduced omega-3 intakes have also been linked to the 
rise in adolescent melancholia, particularly among 
females [20]. Multiple mechanisms undoubtedly 
contribute to the development of depression. However, 
as adolescence is a critical stage in the expansion of 
neural networks, lower brain omega-3 levels may 
negatively influence the neurodevelopment of robust 
emotion-associated signalling [32].
 
Ensuring adequate levels of omega-3 incorporation 
in the developing adolescent seems reasonable to 
ensure optimum organ growth and development. Both 
this study and the West Australian study indicate that 
the majority of Australian adolescents are probably not 
ingesting sufficient amounts of omega-3 to provide 
optimal health [22]. This observation is likely to reflect 
the omega-3 status in adolescent populations of other 
global locations where western-style nutrition patterns 
predominate. However this hypothesis awaits further 
quantitative confirmation. 
The data presented in this report is consistent with 
the proposition that modern urban communities are at 
risk of omega-3 deficiency [33]. As food security for 
developed nations like Australia has been achieved in 
part through the manufacture of edible products with 
long shelf lives, most packaged items are low in the 
easily oxidisable omega-3 PUFAs. Therefore as most 
commonly consumed foods will be low in omega-3 rich 
PUFAs, recommendation of a high quality supplement 
is arguably the most effective method of correcting this 
apparent state of omega-3 fatty acid insufficiency.  
LIMITATIONS 
Though the significant observations in this study are 
statistically valid it is relevant to note that the general 
applicability of some findings may be affected by two 
factors unique to this cohort. 1) Participants recruited 
represent a generally privileged demographic within 
Australia with the largest percentage of students from 
homes in the high socioeconomic band. However as 
this demographic generally has the education and 
financial facility to provide a best-case-healthy 
environment for their children, the significant number of 
adolescents showing below optimum omega-3 levels 
even in this cohort suggests these results may 
underestimate the problem in the wider Australian 
community. 2) This study cohort also had a higher 
percentage of girls than boys. Thus as stated 
previously, the observed gender bias needs to be 
verified. Finally the clinical relevance of the calculated 
omega-3 index remains to be verified for an adolescent 
population as these cut points and calculations are 
based on research carried out in adults.  
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